Protein expression and purification Mammalian cells HEK 293

- Found 9667 results

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Candida tenuis

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Spathaspora passalidarum

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Yarrowia lipolytica

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Candida sonorensis

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Candida albicans

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Saccharomyces cerevisiae

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Yeast - Pichia pastoris

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Get tips on using Y-PER™ Yeast Protein Extraction Reagent to perform Protein isolation Bacteria - Escherichia coli

Products Thermo Fisher Scientific Y-PER™ Yeast Protein Extraction Reagent

Short hairpin or small hairpin RNA (shRNA) is artificial RNA, which has a hairpin loop structure, and uses inherent microRNA (miRNA) machinery to silence target gene expression. This is called RNA interference (RNAi). These can be delivered via plasmids or viral/bacterial vectors. Challenges in shRNA-mediated gene silencing include: 1. Off-target silencing, 2. Packaging shRNA encoding lentivirus, and 3. Stable transduction in cells. RNAi have been designed to have anywhere from 19-27 bs, but the most effective design has 19 bp. In case commercial shRNAs are not available, potential target sites can be chosen within exon, 5’- or 3’ UTR, depending on which splice variants of the gene are desired. One should use the latest algorithms and choose at least two different sequences, targeting different regions, in order to have confidence in overcoming off-target effects. A BLAST search after selecting potential design will eliminate potential off-target sequences. For the second challenge, sequencing the vector using primers for either strand (50-100 bp upstream) is suggested, along with using enzymatic digestion on agarose gel for the vector. Next, once the shRNA-containing vector is packaged in a virus, it is important to check the viral titer before transduction. Finally, using a marker in the lentiviral vector (fluorescent protein or antibiotic resistance), along with qPCR for target gene expression can help in determining efficacy of transduction and shRNA on its target site.

RNA shRNA gene silencing Human Islets of langerhans ZEB1 lentiviral particles

Short hairpin or small hairpin RNA (shRNA) is artificial RNA, which has a hairpin loop structure, and uses inherent microRNA (miRNA) machinery to silence target gene expression. This is called RNA interference (RNAi). These can be delivered via plasmids or viral/bacterial vectors. Challenges in shRNA-mediated gene silencing include: 1. Off-target silencing, 2. Packaging shRNA encoding lentivirus, and 3. Stable transduction in cells. RNAi have been designed to have anywhere from 19-27 bs, but the most effective design has 19 bp. In case commercial shRNAs are not available, potential target sites can be chosen within exon, 5’- or 3’ UTR, depending on which splice variants of the gene are desired. One should use the latest algorithms and choose at least two different sequences, targeting different regions, in order to have confidence in overcoming off-target effects. A BLAST search after selecting potential design will eliminate potential off-target sequences. For the second challenge, sequencing the vector using primers for either strand (50-100 bp upstream) is suggested, along with using enzymatic digestion on agarose gel for the vector. Next, once the shRNA-containing vector is packaged in a virus, it is important to check the viral titer before transduction. Finally, using a marker in the lentiviral vector (fluorescent protein or antibiotic resistance), along with qPCR for target gene expression can help in determining efficacy of transduction and shRNA on its target site.

RNA shRNA gene silencing Human Islets of langerhans Negative control (scrambled) lentiviral particles

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms